Floatz logo

(RS)-KETOPROFEN

Chronic Low-back Pain

Erasme University HospitalSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
81/ 100

Competitive context

19 Active assets in the Chronic Low-back Pain cohort.

Asset / SponsorPhaseRating
NEPENTHE
Uskudar University
Phase 4BB
Duloxetine
University of North Carolina, Chapel Hill
Phase 4BB
Dfn-15
Laboratorios Silanes S.A. de C.V.
Phase 3B
Naproxen
Northwestern University
Phase 2CCC
LEVODOPA
Northwestern University
Phase 2CCC

View all 20 →

Same molecule, other indications

(RS)-KETOPROFEN is also rated in:

sciaticaDormant
BB
Indicative ·
67 / 100
View asset →
Pain ManagementDormant
BB
Indicative ·
64 / 100
View asset →
Pain, PostoperativeDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →